Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 7Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Sarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Hematologic Neoplasms 1Endometrial Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Risk Syndrome 1Breast Neoplasms, Male 1Bone Marrow Failure Disorders 1

Interventions

pembrolizumab 45Paclitaxel 42Carboplatin 34Bevacizumab 18Specimen Handling 17Letrozole 16lenvatinib 13Magnetic Resonance Spectroscopy 12dostarlimab 11Cisplatin 11Biopsy 11Taxes 10olaparib 9Fulvestrant 9Doxorubicin 9abemaciclib 8Megestrol Acetate 8Docetaxel 8durvalumab 7atezolizumab 7Nivolumab 7Gemcitabine 7Blood Specimen Collection 7palbociclib 6Oxaliplatin 6Observation 6Fluorouracil 6niraparib 5Surveys and Questionnaires 5Progestins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Genetic Counseling × 1 year × Clear all
NCT03460483 2025-10-03

OPTEC

Ohio State University Comprehensive Cancer Center

Phase NA Completed
1,001 enrolled
GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡